28th Congress of the European
Association for Cancer Research
Industry Sessions
A programme of sixteen Industry Sponsored Symposia will be available to all participants at the EACR 2022 Congress. This page shows a shapshot of the companies taking part, their talk titles and when/where you can join them.
Quick links to Industry Symposia details:
NanoString Technologies | Monday 20 June - 12:45 – 13:30 | Paris+Brussels Room
"Spatial Whole Transcriptome and single cell high-plex imaging: Quantum leaps forward in studying cancer"
A NanoString Technologlies representative will be joined by a customer who will show the results of their Spatial Biology research in cancer.
During the session participants will: Obtain new ideas, approaches and lessons learned relating to spatial transcriptomics, from two highly innovative, award-winning presentations; Learn more about using spatial transcriptomics in cancer research, including novel methods for discovering spatial biomarkers using the latest digital spatial profiling chemistry; Better understand how they can apply this technology in your research; and Understand how Spatial Profiling and Single Cell analysis complement each other.
During the symposium we will also talk about the EACR-Illumina-NanoString Grant running from 23 May - 04 July 2022.
Lunaphore Technologies | Monday 20 June - 12:45 - 13:30 | Auditorium 2+3
"Hyperplex spatial proteomics made easy with automated sequential IF: how to get most of your research"
Speakers:
- Dr. Charlotte Stadler, Head of the National Spatial Proteomics Facility, SciLifeLab, Sweden
- Dr. Diego Dupouy - CTO, Lunaphore Technologies
Bio-Rad Laboratories | Monday 20 June - 13:45 – 14:30 | Paris+Brussels Room
"A new dimension in multiplexing with Droplet Digital PCR"
"Circulating tumor DNA as a monitoring tool for clinical outcome in patients with advanced stage non-small cell lung cancer treated with immune checkpoint inhibitors" - Ed Schuuring, PhD, Full Professor in Molecular Oncological Pathology and Senior Clinical Scientist in Molecular Pathology, Head of the Laboratory for Molecular Pathology, Department of Pathology (HPC EA10), University Medical Center Groningen, The Netherlands
"QX600 – a new dimension in multiplexing with Droplet Digital PCR" - Marco Giorgio Bianchi, Digital Biology EMEA Product Manager, Life Science Group, Bio-Rad Laboratories s.r.l., Segrate (MI), Italy
Q&A
Bio-Techne | Monday 20 June - 13:45 – 14:30 | Auditorium 2+3
"The power of visualization of diverse RNA biomarkers for in the advancement of translational and clinical cancer research"
Join Bio-Techne to see how ACD’s range of spatial biology solutions are allowing visualisation of a diverse range of RNA biomarkers in translational and clinical cancer research. Understand our range of RNA Spatial Biology products and their application in a range of basic research – translational and clinical cancer workflows. Hear the voices of European and Global cancer researchers about the advances they are making using our unique abilities to understand gene expression ranging from mRNA, Splice variants, small RNA species and use protein/RNA co-detection at a single cell and sub-cellular level. Your opportunity to quiz our RNAscope specialists about how you can apply our range of solutions to your innovative cancer research challenges
Twist Bioscience | Tuesday 21 June - 08:00-08:45 | Paris+Brussels Room
"Writing the Future of C
ancer Research" - Charles Hendricks | Twist Bioscience
"A Systematic & High-Throughput Evaluation of CAR Domains and their Influence on CAR T Cell Performance" - Justin Farlow, PhD I Serotiny
"Homologous Recombination Deficiency and genomic instability in ovarian cancer: “Does one size fit all?" - Liselore Loverix I University Hospital of Leuven
Takara Bio Europe | Tuesday 21 June - 08:00-08:45 | Auditorium 2+3
"Advanced Solutions for Translational Cancer Research: from Discovery to Therapy"
Speakers: Matthieu Pesant & Matthieu Lewis, Senior Market Strategy Managers
10x Genomics | Tuesday 21 June - 13:00-13:45 | Paris+Brussels Room
"Spatial Transcriptomics reveals the impact of plasma cells in cancer control" - Catherine Sautès-Fridman, centre de Recherche des Cordeliers, INSERM U1138 Université Paris Cité
"The immune contexture revisited through spatial transcriptomics" - Hervé Wolf Fridman, centre de Recherche des Cordeliers, INSERM U1138 Université Paris Cité
Akoya Biosciences | Tuesday 21 June - 13:00-13:45 | Auditorium 2+3
"Comprehensive Spatial Phenotyping: Mapping the Tumor Microenvironment at Scale"
Speakers: Amelie Viratham, Technical Applications Scientist, Akoya Biosciences & Eanna Fennell PhD, Post-doctoral Researcher, University of Limerick
Join us for an invigorating spatial discussion, where we show the latest data using the PhenoCycler™-Fusion system, the fastest single-cell spatial biology solution. Our speaker will discuss how whole-slide spatial phenotyping with a 100-plex panel can reveal insights into distinct cellular neighborhoods and explain partial immunotherapy response in a patient sample. We’ll also share the first feasibility data of a novel spatial RNA chemistry that will enable a multiomic workflow on PhenoCycler-Fusion. Additionally, Eanna Fennell PhD, Post-doctoral Researcher at the University of Limerick will describe the utilization of highly multiplexed, single cell spatial phenotyping techniques to quantify the immune microenvironment of Epstein-Barr virus (EBV) associated malignancies and identify virus specific features across both solid and blood cancers.
Thermo Fisher Scientific | Tuesday 21 June - 14:00-14:45 | Paris+Brussels Room
"F
uture biomarkers and methods of detection for Cancer Research"
“Pre-treatment tissue TCR repertoire evenness is associated with complete pathological response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy.” - Marta Casarrubios, Predoctoral Researcher, Puerta de Hierro Hospital, Madrid, Spain
"Longitudinal monitoring by liquid biopsy identifies molecular predictors of resistance in advanced HER2-positive breast cancer" - Dr. Matteo Allegretti, PhD, Researcher, Oncogenomic and Epigenetic Unit, Department of Research and Advanced Technologies, IRCSS Regina Elena National Cancer Institute, Italy
Fluidigm/Standard BioTools | Tuesday 21 June - 14:00-14:45 | Auditorium 2+3
"Towar
ds a Deep Imaging- and Omics-Based Tumor Microenvironment Characterization within the IMMUcan Consortium"
Speaker: Daniel Schulz, The University of Zurich
Cellecta Inc | Wednesday 22 June - 08:00-08:45 | Paris+Brussels Room
"Single Cell CRISPR Screening Identifies Non-Coding RNA Modulating Cancer Plasticity Perturb-seq analysis of TNFalpha-induced transcriptional response" - Donato Tedesco, PhD, Cellecta, Inc., Mountain View, California, USA
"A functional map of LncRNAs involved in adaptation pathways of breast cancer cells" - Matteo Marzi, PhD -Istituto Italiano di Tecnologia, Milan, Italy
Personal Genome Diagnostics | Wednesday 22 June - 08:00-08:45 | Auditorium 2+3
"Bi
omarker discovery within the realm of liquid biopsy"
"Key Benefits of using a Comprehensive Genomic Profiling (CGP) test in the drug development process: a lab experience and perspective" - Killian McSorley, Almac Diagnostic Services
QIAG
EN | Wednesday 22 June - 13:00-13:45 | Paris+Brussels Room
"Single assay for simultaneous detection of 5 different variants of MAP2K1 using multiplexed digital PCR" - Prof. Jean Francois Emile & Zofia Hélias-Rodzewicz, Hopital Ambroise Pare, Boulogne-Billancourt, Paris, France
"The fine art of dPCR – decrypting the MIQE guidelines" - Dr. Afif Abdel Nour, Associate Director, Global Strategic Marketing – Digital PCR, QIAGEN
Illumina | Wednesday 22 June - 13:00-13:45 | Auditorium 2+3
"Spotlight on liquid biopsy: Liquid biopsy as a research tool" - Dr. Anna Babayan, Sr Reg Segment Marketing Manager, Illumina
Additional speaker and title to be confirmed
Q&A
Agilent Technologies | Wednesday 22 June - 14:00-14:45 | Paris+Brussels Room
"Employing metabolic approaches to reveal synthetic lethal targets for succinate dehydrogenase deficient tumors" - Eyal Gottlieb
"New whole comprehensive approach to establish genomic instability profiling in gynecaelogical tumors" - Antonio Fernández-Serra
Bionano 
Genomics | Wednesday 22 June - 14:00-14:45 | Auditorium 2+3
"See More, Know More - Bionano helps you go deeper in the understanding of your complex samples"
"Optical Genome Mapping for the detection of Structural Variation in complex human genomes" - Alicia Bertolotti, Bionano Genomics
"Clinical impact of a genomic combined approach in pediatric central nervous system (CNS) tumors" - Silvia Genovese, Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, Rome, Italy
"Complex rearrangement patterns in Ewing sarcoma associate with poor clinical outcome" - Juan Díaz-Martín, Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital /CSIC/University of Sevilla/CIBERONC, Spain
|
Auditorium 2+3 |
Brussels+Paris Room |
|
Lunaphore Technologies |
NanoString Technologies |
|
Bio-Techne |
Bio-Rad Laboratories |
|
Takara Bio Europe |
Twist Bioscience |
|
Akoya Biosciences |
10x Genomics |
|
Fluidigm/Standard Bio Tools |
Thermo Fisher Scientific |
|
Personal Genome Diagnostics |
Cellecta |
|
Illumina |
QIAGEN |
|
Bionano Genomics |
Agilent Technologies |
Six 15-minute industry spotlights will also take place within the exhibition during the Welcome Reception, coffee breaks and Poster Sessions.
|
CancerTools.org |
Thermo Fisher Scientific |
|
Bio-Techne |
NanoString Technologies |
|
QIAGEN |
Cellecta |
Sorry. You need to upgrade your browser
You are using Internet Explorer 8
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.
Thank you.